These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 2785325)

  • 41. Osteocalcin serum levels in patients following renal transplantation.
    Schmidt H; Stracke H; Schatz H; Scheuermann EH; Fassbinder W; Schoeppe W
    Klin Wochenschr; 1989 Mar; 67(5):297-303. PubMed ID: 2651790
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biochemical variables associated with bone density in patients with primary hyperparathyroidism.
    Bergenfelz A; Lindergård B; Ahrén B
    Eur J Surg; 1992 Sep; 158(9):473-6. PubMed ID: 1358213
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay.
    Garnero P; Grimaux M; Demiaux B; Preaudat C; Seguin P; Delmas PD
    J Bone Miner Res; 1992 Dec; 7(12):1389-98. PubMed ID: 1481725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effects of high dose pulse oral calcitriol on secondary hyperparathyroidism in patients with end-stage renal disease].
    Yang J; Luo N; Liang J
    Zhonghua Nei Ke Za Zhi; 1996 Feb; 35(2):89-91. PubMed ID: 9275624
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of salmon calcitonin on bone mineral density and calcium-phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism].
    Matuszkiewicz-Rowińska J; Niemczyk S; Przedlacki J; Puka J; Switalski M; Ostrowski K
    Pol Arch Med Wewn; 2004 Jul; 112(1):797-803. PubMed ID: 15526839
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evolution of osteocalcin, alkaline phosphatase and parathyroid hormone after parathyroidectomy in patients receiving chronic maintenance hemodialysis.
    Peretz AM; Dhaene MM; Drowart A; Kinnaert P; Vertongen FM; Bourdoux PP
    J Rheumatol; 1992 Mar; 19(3):411-5. PubMed ID: 1578455
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of calcium infusion on calcitonin and parathyroid hormone concentrations in normal and hemodialyzed subjects.
    Isaac R; Nivez MP; Piamba G; Fillastre JP; Ardaillou R
    Clin Nephrol; 1975 Jan; 3(1):14-7. PubMed ID: 1126058
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical significance of serum bone Gla protein and urinary gamma-Gla as biochemical markers in primary hyperparathyroidism.
    Yoneda M; Takatsuki K; Oiso Y; Takano T; Kurokawa M; Ota A; Tomita A; Ohno T; Okano K; Kanazawa T
    Endocrinol Jpn; 1986 Feb; 33(1):89-94. PubMed ID: 3487445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum osteocalcin levels in normal subjects and patients with primary hyperparathyroidism.
    Ljunghall S; Hällgren R; Rastad J
    Exp Clin Endocrinol; 1985 Dec; 86(2):218-22. PubMed ID: 3879222
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Mechanism of the decrease in metacarpal bone mineral content due to oophorectomy].
    Ohta H; Nemoto K; Nozawa S; Iizuka R
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Mar; 41(3):333-40. PubMed ID: 2786542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Undercarboxylated osteocalcin (Glu-OC) bone metabolism and vascular calcification in hemodialyzed patients].
    Bentkowski W; Kuźniewski M; Fedak D; Dumnicka P; Kuśnierz-Cabala B; Janda K; Sułowicz W
    Przegl Lek; 2013; 70(9):703-6. PubMed ID: 24455828
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Osteocalcin and urinary hydroxyproline/creatinine ratio in the differential diagnosis of primary hyperparathyroidism and hypercalcaemia of malignancy.
    de la Piedra C; Toural V; Rapado A
    Scand J Clin Lab Invest; 1987 Oct; 47(6):587-92. PubMed ID: 3499657
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum osteocalcin or bone Gla-protein, a biochemical marker for bone metabolism in horses: differences in serum levels with age.
    Lepage OM; Marcoux M; Tremblay A
    Can J Vet Res; 1990 Apr; 54(2):223-6. PubMed ID: 2357658
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of programmed hemodialysis on serum alkaline phosphatase in patients with chronic renal insufficiency].
    Basova NI; Zavarzina TM; Terekhov NT; Petrun' NM
    Vrach Delo; 1977 Jul; (7):99-103. PubMed ID: 898887
    [No Abstract]   [Full Text] [Related]  

  • 55. Risk Factors of Parathyroid Dysfunction in Elderly Patients with Chronic Kidney Disease Undergoing Hemodialysis.
    Li W; Zhang S
    Adv Clin Exp Med; 2015; 24(6):1007-12. PubMed ID: 26771973
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The effect of hyperprolactinemia on biohumoral parameters of bone metabolism in women of reproductive age on chronic hemodialysis].
    Petrović MS; Prelević GM; Balint-Perić LjA; Radmilović AV
    Srp Arh Celok Lek; 1992; 120(1-2):15-8. PubMed ID: 1641694
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Alkaline phosphatase of bone origin in hemodialyzed patients. 110 assays].
    Ureña P; Prieur P; Pétrover M
    Presse Med; 1996 Oct; 25(29):1320-5. PubMed ID: 8942941
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum osteocalcin levels in primary hyperparathyroidism.
    Pietschmann P; Niederle B; Anvari A; Woloszczuk W
    Klin Wochenschr; 1991 May; 69(8):351-3. PubMed ID: 1886398
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Secondary hyperparathyroidism: comparison of clinical findings with the degree of early parathyroid hyperplasia (author's transl)].
    Ries P; Hebrmann R; Thiele J
    Dtsch Med Wochenschr; 1977 Sep; 102(39):1381-4. PubMed ID: 913257
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients.
    Bervoets AR; Spasovski GB; Behets GJ; Dams G; Polenakovic MH; Zafirovska K; Van Hoof VO; De Broe ME; D'Haese PC
    Am J Kidney Dis; 2003 May; 41(5):997-1007. PubMed ID: 12722034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.